Brief: Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco
17/06/2026 02:39
BRIEF-Neurizon Therapeutics Executes Long-Term Supply Agreement With Elanco June 17 (Reuters) - Neurizon Therapeutics Ltd NUZ.AX:
NEURIZON THERAPEUTICS LTD-NEURIZON EXECUTES LONG-TERM SUPPLY AGREEMENT WITH ELANCO
NEURIZON THERAPEUTICS - EXECUTES FIVE-YEAR SUPPLY AGREEMENT WITH ELANCO ANIMAL HEALTH
NEURIZON THERAPEUTICS - AGREEMENT SECURES LONG-TERM GMP MONEPANTEL SUPPLY FOR NUZ-1
NEURIZON THERAPEUTICS - TO EXCLUSIVELY BUY MONEPANTEL FROM ELANCO WITH SPECIFIC ALTERNATIVE RIGHTS
Further company coverage: NUZ.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neurizon Therapeutics
See all newsAustralia's Neurizon jumps on potential for neurodegenerative drug approval
Brief: Neurizon Therapeutics' Ongoing Healey ALS Platform Trial Affirmed By FDA
Brief: Neurizon Therapeutics Says Dr Chris Bremer Commences As CEO
Brief: Neurizon Therapeutics Appoints Chris Bremer As Chief Executive Officer
Brief: Neurizon Therapeutics Enters Strategic Research And Development Financing Facility